APLS
Apellis Pharmaceuticals Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $66.43
- Day High
- $66.54
- Day Low
- $64.44
- Day Open
- $64.76
- Volume
- 65142
- Day Change
- 3.13%
Latest news data for APLS
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Shares Sold by SG Americas Securities LLC
etfdailynews.com
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Increased to $52.00 by Analysts at Credit Suisse Group
etfdailynews.com
AJU IB Investment Co., Ltd. Buys 3, Sells 2 in 2nd Quarter
gurufocus.com
Apellis Pharmaceuticals, Inc. : Credit Suisse est neutre sur le titre
zonebourse.com
Apellis Pharmaceuticals, Inc. : Goldman Sachs persiste ?'achat
zonebourse.com
Apellis Pharmaceuticals, Inc. : Raymond James toujours positif
zonebourse.com
Apellis Pharmaceuticals, Inc. : Wedbush conserve son opinion neutre
zonebourse.com
Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com
Apellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:APLS)
seekingalpha.com
Apellis Pharmaceuticals, Inc. (APLS) Reports Q2 Loss, Misses Revenue Estimates
zacks.com